AIチャット
Loading data for EW — first visit, this takes a few seconds.

Edwards Lifesciences Corporation

EW · NYSE · USD

89.28 +3.54 (4.13%)

終値時点: Sep 16, 2026, 3:59 PM

89.81 +0.59%

寄り付き前: 8:37 AM

時価総額
$51.46B
出来高
5.01M

Edwards Lifesciences Corporation(EW)の株価・分析・データ

本質的価値

本源的価値を読み込み中…

アナリスト予想

株価予想 →

アナリスト予測は利用できません

12か月目標株価 · アナリストn/a人

アナリストのコンセンサス: n/a

間隔:1D
ローソク足とシグナルを読み込み中…

業績

財務情報を見る →

読み込み中...

最新決算

実績予想との差前年比
売上高n/an/a
EPS(TTM)$0.78+$0.04+16.42%

次回決算

引け後の予定です。

予想 · アップグレード →

決算の詳細を見る →

事業指標

買気配
0
純利益(TTM)
980M
0.85
1.68
53.14
26.44
PBR(TTM)
4.85
PSR(TTM)
7.89
決算発表日
Oct 29, 2026
売気配
90.1
出来高
5,011,504
平均出来高(20日)
4,105,759
始値
84.99
前日終値
85.74
当日レンジ
85.49 - 89.70
52週レンジ
72.30 - 96.29
配当
n/a
権利落ち日
n/a

Edwards Lifesciences Corporationについて

企業情報を見る →
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California. Medical Devices · Healthcare

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

セクター Healthcare
IPO日 Mar 27, 2000
従業員数 16,000
上場取引所 NYSE
ティッカー EW
ウェブサイト https://www.edwards.com